Update on the CAPTIVATE trial of ibrutinib plus venetoclax

Clin Adv Hematol Oncol. 2023 Dec;21(12):654-657.

Author

Tanya Siddiqi^{1

2}

Affiliations

¹ Division of Lymphoma, City of Hope Orange County, Duarte, California.
² Department of Hematology/HCT, City of Hope, Duarte, California.

PMID: 38039059

No abstract available

Publication types

Interview

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
Clinical Trials as Topic
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Piperidines / therapeutic use
Sulfonamides / therapeutic use

Substances

Bridged Bicyclo Compounds, Heterocyclic
ibrutinib
Piperidines
Sulfonamides
venetoclax